Search by Drug Name or NDC
NDC 44523-0604-01 SODIUM SULFACETAMIDE, SULFUR 100; 50 mg/g; mg/g Details
SODIUM SULFACETAMIDE, SULFUR 100; 50 mg/g; mg/g
SODIUM SULFACETAMIDE, SULFUR is a TOPICAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BioComp Pharma, Inc.. The primary component is SULFACETAMIDE SODIUM; SULFUR.
Product Information
| NDC | 44523-0604 |
|---|---|
| Product ID | 44523-604_f79914d3-c3c4-8601-e053-6294a90aefb3 |
| Associated GPIs | 90059903201820 |
| GCN Sequence Number | 047717 |
| GCN Sequence Number Description | sulfacetamide sodium/sulfur SUSPENSION 10-5%(W/W) TOPICAL |
| HIC3 | Q5S |
| HIC3 Description | TOPICAL SULFONAMIDES |
| GCN | 12691 |
| HICL Sequence Number | 003344 |
| HICL Sequence Number Description | SULFACETAMIDE SODIUM/SULFUR |
| Brand/Generic | Generic |
| Proprietary Name | SODIUM SULFACETAMIDE, SULFUR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sulfacetamide sodium, sulfur |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | TOPICAL |
| Active Ingredient Strength | 100; 50 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | SULFACETAMIDE SODIUM; SULFUR |
| Labeler Name | BioComp Pharma, Inc. |
| Pharmaceutical Class | Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44523-0604-01 (44523060401)
| NDC Package Code | 44523-604-01 |
|---|---|
| Billing NDC | 44523060401 |
| Package | 30 g in 1 BOTTLE, PLASTIC (44523-604-01) |
| Marketing Start Date | 2011-06-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |